Indegene Limited (NSE: INDGN)
India
· Delayed Price · Currency is INR
590.00
+1.20 (0.20%)
Dec 24, 2024, 3:29 PM IST
Indegene Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Revenue | 27,097 | 25,896 | 23,061 | 16,646 | 9,663 | 6,429 |
Other Revenue | - | - | - | - | 143.04 | 6.74 |
Revenue | 27,097 | 25,896 | 23,061 | 16,646 | 9,806 | 6,436 |
Revenue Growth (YoY) | - | 12.29% | 38.54% | 69.76% | 52.36% | - |
Cost of Revenue | 588 | 588 | 412 | 324.59 | 156.46 | 109.71 |
Gross Profit | 26,509 | 25,308 | 22,649 | 16,322 | 9,649 | 6,326 |
Selling, General & Admin | 17,322 | 16,560 | 14,688 | 10,216 | 5,403 | 3,737 |
Other Operating Expenses | 3,707 | 3,640 | 4,000 | 3,231 | 1,798 | 1,145 |
Operating Expenses | 21,785 | 20,961 | 19,286 | 13,787 | 7,456 | 5,076 |
Operating Income | 4,724 | 4,347 | 3,363 | 2,535 | 2,193 | 1,250 |
Interest Expense | -370 | -463 | -233 | -46.7 | -55.05 | -67.92 |
Interest & Investment Income | 296 | 296 | 103 | 8.03 | 8.85 | 9.08 |
Earnings From Equity Investments | - | - | - | - | -2 | 5.28 |
Currency Exchange Gain (Loss) | 162 | 162 | 398 | 189.74 | 62.46 | 18.68 |
Other Non Operating Income (Expenses) | 34 | -5 | -70 | -1.96 | -4.8 | -20.43 |
EBT Excluding Unusual Items | 4,846 | 4,337 | 3,561 | 2,684 | 2,202 | 1,195 |
Impairment of Goodwill | -911 | -911 | - | - | - | - |
Gain (Loss) on Sale of Investments | 165 | 165 | 69 | 50.14 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 82.39 | - |
Other Unusual Items | 995 | 995 | - | -468.99 | 29.89 | -436.6 |
Pretax Income | 5,095 | 4,586 | 3,630 | 2,265 | 2,315 | 758 |
Income Tax Expense | 1,365 | 1,219 | 969 | 636.78 | 457.8 | 261.16 |
Earnings From Continuing Operations | 3,730 | 3,367 | 2,661 | 1,628 | 1,857 | 496.84 |
Earnings From Discontinued Operations | - | - | - | - | -362.69 | -621.07 |
Net Income to Company | 3,730 | 3,367 | 2,661 | 1,628 | 1,494 | -124.23 |
Minority Interest in Earnings | - | - | - | 19.44 | -0.08 | 61.24 |
Net Income | 3,730 | 3,367 | 2,661 | 1,648 | 1,494 | -62.99 |
Net Income to Common | 3,730 | 3,367 | 2,661 | 1,648 | 1,494 | -62.99 |
Net Income Growth | - | 26.53% | 61.51% | 10.28% | - | - |
Shares Outstanding (Basic) | 229 | 222 | 221 | 220 | 198 | 197 |
Shares Outstanding (Diluted) | 231 | 223 | 222 | 221 | 209 | 197 |
Shares Change (YoY) | 3.95% | 0.54% | 0.71% | 5.64% | 5.84% | - |
EPS (Basic) | 16.32 | 15.19 | 12.03 | 7.51 | 7.56 | -0.32 |
EPS (Diluted) | 16.17 | 15.07 | 11.97 | 7.46 | 5.27 | -0.32 |
EPS Growth | - | 25.90% | 60.46% | 41.50% | - | - |
Free Cash Flow | 4,302 | 4,970 | 1,114 | 2,723 | 1,514 | 162.21 |
Free Cash Flow Per Share | 18.65 | 22.24 | 5.01 | 12.34 | 7.25 | 0.82 |
Gross Margin | 97.83% | 97.73% | 98.21% | 98.05% | 98.40% | 98.30% |
Operating Margin | 17.43% | 16.79% | 14.58% | 15.23% | 22.36% | 19.42% |
Profit Margin | 13.77% | 13.00% | 11.54% | 9.90% | 15.24% | -0.98% |
Free Cash Flow Margin | 15.88% | 19.19% | 4.83% | 16.36% | 15.44% | 2.52% |
EBITDA | 5,225 | 4,853 | 3,735 | 2,729 | 2,323 | 1,340 |
EBITDA Margin | 19.28% | 18.74% | 16.20% | 16.39% | 23.69% | 20.81% |
D&A For EBITDA | 501 | 506 | 372 | 193.82 | 130.34 | 89.75 |
EBIT | 4,724 | 4,347 | 3,363 | 2,535 | 2,193 | 1,250 |
EBIT Margin | 17.43% | 16.79% | 14.58% | 15.23% | 22.36% | 19.42% |
Effective Tax Rate | 26.79% | 26.58% | 26.69% | 28.11% | 19.78% | 34.45% |
Revenue as Reported | 27,899 | 26,659 | 23,641 | 16,905 | 9,969 | 6,464 |
Source: S&P Capital IQ. Standard template. Financial Sources.